What is Legal Insider Trading? How do I use this site?
Learn More ›
Login/Signup
Top Companies
Form Screener
Random Insider
Random Company
Sectors
FAQ
Feedback
Blog
Pricing
FATE THERAPEUTICS INC (FATE)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
BUY
20 Apr 2023
Redmile Group, LLC
Director, 10% Owner
FATE THERAPEUTICS INC
(FATE)
13,135,758
+2%
276,639
$6.17
$1,705,829.00
SELL
18 Apr 2023
Chu Yu-Waye
Chief Medical Officer, Officer
FATE THERAPEUTICS INC
(FATE)
142,993
-1%
2,532
$6.57
$16,647.66
SELL
13 Apr 2023
Redmile Group, LLC
Director, 10% Owner
FATE THERAPEUTICS INC
(FATE)
12,833,419
-2%
276,639
$5.85
$1,611,459.80
SELL
31 Jan 2023
Daniel Goldman
Congressman (House)
FATE THERAPEUTICS INC
(FATE)
N/A
N/A
N/A
$1,001 - $15,000
BUY
11 Jan 2023
MENDLEIN JOHN
Director
FATE THERAPEUTICS INC
(FATE)
282,770
+78%
124,679
$5.60
$698,138.50
SELL
10 Jan 2023
Dulac Edward J III
Chief Financial Officer, Officer
FATE THERAPEUTICS INC
(FATE)
129,470
-5%
7,331
$5.24
$38,414.44
SELL
10 Jan 2023
Chu Yu-Waye
Chief Medical Officer, Officer
FATE THERAPEUTICS INC
(FATE)
143,208
-5%
7,825
$5.24
$41,003.00
SELL
10 Jan 2023
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
177,598
-6%
11,553
$5.24
$60,537.72
SELL
10 Jan 2023
Plavsic Mark
Chief Technical Officer, Officer
FATE THERAPEUTICS INC
(FATE)
123,705
-2%
3,418
$5.24
$17,910.32
SELL
10 Jan 2023
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
385,639
-10%
45,907
$5.24
$240,552.67
SELL
10 Jan 2023
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
168,917
-6%
10,917
$5.24
$57,205.08
SELL
18 Aug 2022
Dulac Edward J III
Chief Financial Officer, Officer
FATE THERAPEUTICS INC
(FATE)
137,233
-3%
5,135
$29.81
$153,051.38
SELL
21 Jul 2022
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
434,869
-7%
36,246
$32.74
$1,186,716.80
SELL
7 Jul 2022
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
179,834
-8%
17,158
$30.23
$518,686.34
SELL
6 Jul 2022
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
179,834
-4%
7,842
$30.07
$235,808.94
SELL
5 Jul 2022
Plavsic Mark
Chief Technical Officer, Officer
FATE THERAPEUTICS INC
(FATE)
127,123
-2%
3,719
$24.61
$91,524.59
SELL
7 Jun 2022
Agarwal Shefali
Director
FATE THERAPEUTICS INC
(FATE)
1,840
-31%
841
$21.89
$18,409.49
SELL
3 Jun 2022
Jooss Karin
Director
FATE THERAPEUTICS INC
(FATE)
1,198
-55%
1,483
$22.82
$33,842.06
SELL
3 Jun 2022
COUGHLIN TIMOTHY
Director
FATE THERAPEUTICS INC
(FATE)
57,632
-2%
1,439
$22.81
$32,823.59
SELL
3 Jun 2022
Agarwal Shefali
Director
FATE THERAPEUTICS INC
(FATE)
1,874
-30%
807
$22.80
$18,399.60
SELL
3 Jun 2022
MENDLEIN JOHN
Director
FATE THERAPEUTICS INC
(FATE)
158,091
-0%
1,364
$22.79
$31,085.56
SELL
3 Jun 2022
HERSHBERG ROBERT
Director
FATE THERAPEUTICS INC
(FATE)
2,009
-25%
672
$22.75
$15,288.00
SELL
1 Jun 2022
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
189,151
-11%
25,000
$22.96
$574,000.00
SELL
21 Apr 2022
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
432,384
-8%
40,000
$34.89
$1,395,791.80
SELL
19 Apr 2022
Chu Yu-Waye
Chief Medical Officer, Officer
FATE THERAPEUTICS INC
(FATE)
151,033
-2%
4,062
$35.37
$143,672.94
SELL
14 Mar 2022
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
188,156
-11%
25,000
$31.07
$776,732.90
SELL
10 Mar 2022
MENDLEIN JOHN
Director
FATE THERAPEUTICS INC
(FATE)
171,524
-15%
31,562
$35.02
$1,105,200.00
SELL
20 Jan 2022
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
431,546
-8%
40,000
$39.66
$1,586,500.00
SELL
11 Jan 2022
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
156,385
-3%
5,419
$48.53
$262,974.56
SELL
11 Jan 2022
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
436,065
-3%
14,566
$48.68
$709,026.80
SELL
11 Jan 2022
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
146,950
-3%
4,570
$48.50
$221,655.03
SELL
11 Jan 2022
Dulac Edward J III
Chief Financial Officer, Officer
FATE THERAPEUTICS INC
(FATE)
109,024
-1%
1,770
$48.45
$85,757.40
SELL
11 Jan 2022
Chu Yu-Waye
Senior VP Clinical Development, Officer
FATE THERAPEUTICS INC
(FATE)
122,211
-3%
3,965
$48.51
$192,340.47
SELL
10 Jan 2022
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
161,911
-4%
7,738
$46.43
$359,312.60
SELL
10 Jan 2022
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
467,107
-6%
34,156
$46.86
$1,600,533.60
SELL
10 Jan 2022
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
151,453
-3%
5,596
$46.38
$259,557.53
SELL
3 Jan 2022
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
214,579
-18%
50,000
$59.34
$2,966,853.00
SELL
20 Dec 2021
Dulac Edward J III
Chief Financial Officer, Officer
FATE THERAPEUTICS INC
(FATE)
110,404
-12%
15,977
$60.00
$958,620.00
SELL
13 Dec 2021
Valamehr Bahram
Chief R&D Officer, Officer
FATE THERAPEUTICS INC
(FATE)
179,598
-12%
25,000
$47.66
$1,191,405.50
SELL
10 Dec 2021
Chu Yu-Waye
Senior VP Clinical Development, Officer
FATE THERAPEUTICS INC
(FATE)
131,161
-5%
7,500
$51.46
$385,947.90
SELL
18 Nov 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
393,793
-4%
20,000
$54.27
$1,085,400.00
SELL
21 Oct 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
393,793
-13%
60,000
$59.55
$3,572,959.50
SELL
1 Oct 2021
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
141,736
-26%
50,000
$58.83
$2,941,462.00
SELL
28 Sep 2021
Dulac Edward J III
Chief Financial Officer, Officer
FATE THERAPEUTICS INC
(FATE)
52,404
-27%
19,460
$62.53
$1,216,833.80
SELL
13 Sep 2021
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
104,931
-19%
25,000
$66.29
$1,657,257.50
SELL
19 Aug 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
393,793
-4%
20,000
$88.01
$1,760,204.00
SELL
19 Aug 2021
Dulac Edward J III
Chief Financial Officer, Officer
FATE THERAPEUTICS INC
(FATE)
56,076
-5%
3,474
$88.26
$306,602.40
SELL
22 Jul 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
393,793
-13%
60,000
$85.67
$5,140,113.50
SELL
1 Jul 2021
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
163,482
-25%
55,534
$85.24
$4,733,743.50
SELL
14 Jun 2021
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
104,360
-19%
25,000
$89.32
$2,233,045.20
SELL
20 May 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
393,793
-4%
20,000
$77.16
$1,543,291.90
SELL
22 Apr 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
393,793
-13%
60,000
$85.39
$5,123,496.00
SELL
16 Apr 2021
Chu Yu-Waye
Senior VP Clinical Development, Officer
FATE THERAPEUTICS INC
(FATE)
67,200
-4%
3,275
$83.30
$272,809.00
SELL
1 Apr 2021
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
189,151
-11%
25,000
$38.85
$971,249.94
SELL
1 Apr 2021
TAHL CINDY
See Remarks, Officer
FATE THERAPEUTICS INC
(FATE)
137,048
-17%
30,000
$83.81
$2,514,329.00
SELL
15 Mar 2021
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
116,783
-17%
25,000
$92.35
$2,308,772.00
SELL
8 Mar 2021
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
94,722
-20%
25,000
$81.74
$2,043,428.40
SELL
18 Feb 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
412,392
-4%
20,000
$102.01
$2,040,258.10
SELL
20 Jan 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
411,026
-12%
60,000
$100.67
$6,039,968.50
SELL
19 Jan 2021
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
109,200
-24%
35,000
$114.76
$4,016,639.20
SELL
8 Jan 2021
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
91,957
-9%
9,483
$114.94
$1,090,021.10
SELL
8 Jan 2021
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
355,634
-16%
69,407
$116.33
$8,073,771.50
SELL
8 Jan 2021
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
79,649
-10%
9,484
$114.95
$1,090,139.90
SELL
8 Jan 2021
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
85,530
-9%
9,482
$114.95
$1,089,911.50
BUY
8 Jan 2021
Redmile Group, LLC
Director, 10% Owner
FATE THERAPEUTICS INC
(FATE)
12,957,222
+2%
327,485
$85.50
$27,999,968.00
SELL
17 Dec 2020
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
436,801
-4%
20,000
$91.82
$1,836,351.80
SELL
14 Dec 2020
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
110,398
-18%
25,000
$97.78
$2,444,477.00
SELL
16 Nov 2020
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
113,159
-18%
25,000
$51.83
$1,295,745.80
SELL
12 Nov 2020
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
419,969
-12%
60,000
$51.87
$3,112,423.50
SELL
4 Nov 2020
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
102,118
-40%
70,801
$50.47
$3,573,391.50
SELL
16 Oct 2020
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
99,518
-22%
29,199
$50.25
$1,467,211.80
SELL
1 Oct 2020
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
112,761
-23%
35,000
$40.74
$1,426,065.10
SELL
14 Sep 2020
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
111,611
-18%
25,000
$36.28
$907,024.44
SELL
14 Sep 2020
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
141,691
-14%
25,000
$36.30
$907,539.56
BUY
11 Jun 2020
Redmile Group, LLC
Director, 10% Owner
FATE THERAPEUTICS INC
(FATE)
12,629,737
+12%
1,412,928
$28.31
$39,999,990.00
SELL
30 Jan 2020
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
419,969
-5%
25,000
$25.45
$636,302.50
SELL
8 Jan 2020
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
99,518
-5%
5,700
$20.72
$118,085.19
SELL
8 Jan 2020
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
86,058
-6%
5,700
$20.69
$117,947.24
SELL
8 Jan 2020
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
143,091
-3%
5,700
$20.70
$117,986.02
SELL
30 Dec 2019
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
123,891
-16%
25,000
$19.50
$487,427.12
SELL
19 Dec 2019
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
353,969
-12%
50,000
$20.12
$1,006,055.00
SELL
15 Oct 2019
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
80,218
-11%
10,200
$14.24
$145,291.86
SELL
15 Oct 2019
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
353,969
-5%
21,017
$14.44
$303,458.16
SELL
15 Oct 2019
Valamehr Bahram
Chief Development Officer, Officer
FATE THERAPEUTICS INC
(FATE)
66,758
-8%
6,200
$14.18
$87,890.59
SELL
15 Oct 2019
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
123,791
-8%
11,800
$14.29
$168,592.50
BUY
16 Sep 2019
Redmile Group, LLC
Director, 10% Owner
FATE THERAPEUTICS INC
(FATE)
11,216,809
+8%
857,143
$17.50
$15,000,002.00
SELL
31 Jul 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,099,772
-5%
62,005
$22.53
$1,397,066.20
SELL
26 Jul 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,159,599
-9%
118,333
$22.51
$2,663,114.80
SELL
23 Jul 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,273,778
-6%
81,899
$22.51
$1,843,151.00
SELL
18 Jul 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,352,800
-4%
71,166
$22.52
$1,602,505.80
SELL
27 Jun 2019
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
135,591
-8%
12,500
$20.21
$252,609.98
SELL
16 May 2019
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
386,918
-3%
14,335
$19.37
$277,683.80
SELL
17 Apr 2019
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
374,881
-5%
20,000
$16.08
$321,641.20
SELL
28 Mar 2019
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
135,591
-8%
12,500
$16.94
$211,702.48
SELL
21 Mar 2019
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
374,881
-5%
20,000
$17.61
$352,160.00
SELL
1 Mar 2019
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
90,418
-21%
25,000
$16.15
$403,697.50
SELL
25 Feb 2019
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
90,418
-21%
25,000
$16.07
$401,820.00
SELL
30 Jan 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,474,979
-3%
53,017
$14.16
$750,959.40
SELL
29 Jan 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,529,622
-5%
97,500
$14.16
$1,380,795.20
SELL
28 Jan 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,626,157
-4%
70,000
$13.78
$964,768.00
SELL
25 Jan 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,696,859
-5%
90,000
$14.14
$1,272,752.90
SELL
18 Jan 2019
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,785,088
-2%
39,483
$16.28
$642,834.30
SELL
7 Jan 2019
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
45,418
-35%
25,000
$16.00
$400,000.00
SELL
20 Dec 2018
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,824,360
-1%
33,474
$12.25
$410,160.30
SELL
19 Dec 2018
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,882,881
-4%
91,210
$13.40
$1,222,592.20
SELL
13 Dec 2018
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,948,494
-0%
17,788
$16.67
$296,563.30
SELL
12 Dec 2018
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
1,980,561
-17%
425,000
$16.78
$7,132,690.50
SELL
11 Dec 2018
Nashat Amir
Director
FATE THERAPEUTICS INC
(FATE)
2,393,552
-3%
82,528
$16.71
$1,379,183.10
BUY
25 Sep 2018
Redmile Group, LLC
Director, 10% Owner
FATE THERAPEUTICS INC
(FATE)
10,359,666
+55%
3,703,704
$13.50
$50,000,004.00
SELL
13 Oct 2017
TAHL CINDY
General Counsel and Secretary, Officer
FATE THERAPEUTICS INC
(FATE)
45,418
-15%
8,091
$3.85
$31,123.53
SELL
13 Oct 2017
Wolchko J Scott
President and CEO, Director, Officer
FATE THERAPEUTICS INC
(FATE)
124,881
-12%
17,168
$3.88
$66,600.16
SELL
13 Oct 2017
Shoemaker Daniel D
Chief Scientific Officer, Officer
FATE THERAPEUTICS INC
(FATE)
90,591
-12%
13,225
$3.87
$51,202.50
BUY
23 Nov 2016
Coughlin Timothy P
Director
FATE THERAPEUTICS INC
(FATE)
56,390
+100%
56,390
$2.66
$149,997.40
BUY
23 Nov 2016
Storgard Chris
Chief Medical Officer, Officer
FATE THERAPEUTICS INC
(FATE)
37,593
+100%
37,593
$2.66
$99,997.38
BUY
23 Nov 2016
RASTETTER WILLIAM H
Director
FATE THERAPEUTICS INC
(FATE)
459,272
+451%
375,939
$2.66
$999,997.75
Home